KLA Corporation

The filings show a company whose reported revenue grew sharply in fiscal 2025, while its risk disclosures focus on whether that business can keep operating in China. The most specific items are the BIS rule series named in Item 1A, the Entity List additions, the advanced DRAM restriction, and the Affiliates Rule, whose full text is cut off in the excerpt. The 10-Q says there are no material changes to market risk and no changes to internal control over financial reporting, and that disclosure controls were effective at a reasonable assurance level. Credit ratings were listed as Fitch A, Moody's A2 and S&P Global A-, and the filing names operating performance, industry conditions and material acquisitions as factors that could change them. The 10-Q incorporates Note 13 on litigation and Note 14 on indemnification by reference, but those notes are not in the provided text, so no legal exposure can be assessed here. The risk factors also mention receivables factoring, government R&D funding subject to audit, and possible restructuring or inventory write-offs, none of which are quantified in the excerpts. No forensic scores were provided for this synthesis, so none are assessed; a Beneish, Piotroski, Altman or Fog reading is not part of this analysis. The provided operating income figures end in fiscal 2014, so this synthesis cannot assess recent profitability, margins or cash generation from the data supplied. Readers may want to look at the full fiscal 2025 financial statements, the cash flow statement, Notes 13 and 14, and the complete Affiliates Rule discussion to test the export-control exposure against reported results.

Catalyst.Revenue is the clearest driver in the data. Fiscal 2025 revenue was $12.16 billion, up from $9.81 billion in fiscal 2024, an increase of $2.35 billion or about 24 percent. That followed a decline from $10.5 billion in fiscal 2023 to $9.81 billion in fiscal 2024. In the 10-Q for the period ended March 31, 2026, working capital was $7.60 billion, up $986.4 million from $6.61 billion at June 30, 2025. Management cites $4.96 billion of cash, cash equivalents and marketable securities plus $1.50 billion of Revolving Credit Facility availability, and says these should cover working capital, capital expenditures, cash dividends, stock repurchases and contractual obligations for at least the next 12 months. The excerpts do not explain what drove the revenue growth.

Hidden risk.The most material tension is export controls. The risk factors state that Commerce rules may significantly harm results, cash flows and financial condition unless licenses are obtained. They describe the 2022 BIS Rules, the 2023 BIS Rules, the 2024 and 2025 BIS Rules that added Entity List companies and revised the advanced DRAM definition, and a September 2025 interim final rule, the Affiliates Rule, which extends licensing requirements to foreign entities 50% or more owned by listed parties. The same risk factors cite a highly concentrated customer base and a debt and leveraged capital structure. The excerpts do not quantify China revenue, customer concentration or debt, so a reader may want to look at those figures in the full filing.